POPULARITY
21 episodes with endometrial
15 episodes with endometrial
7 episodes with endometrial
8 episodes with endometrial
5 episodes with endometrial
8 episodes with endometrial
6 episodes with endometrial
6 episodes with endometrial
6 episodes with endometrial
Q-BANK: https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Definition (1:44),PALM-COEIN (2:48),Diagnostic approach (3:51),Endometrial polyps (5:39),Adenomyosis (7:37),Endometriosis (9:40),Leiomyoma (11:28),Endometrial hyperplasia and cancer (13:37), Coagulopathy (15:59),Polyendocrine Metabolic Ovarian Syndrome (17:20),Iatrogenic (20:02),Practice Questions (21:22)
In this episode, we review the high-yield topic of Endometrial Carcinoma from the Oncology section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
Endometrial cancer is the most common gynecologic cancer in the United States and the fourth most common cancer affecting women. One of its most important warning signs – abnormal vaginal bleeding or spotting – is something many women experience and may dismiss. While survival rates exceed 95%, both overall incidence and mortality rates are rising. In this episode, we speak with Ursula A. Matulonis, MD, chief of the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute, about the symptoms of endometrial cancer, the role family history plays in risk, and the lifestyle habits that may help lower your chances of developing the disease. Credits Host: Neha Pathak, MD, FACP, DipABLM Producer/Editor: Lauren Summers Show Notes: Lauren Summers Guest: Ursula A. Matulonis, MD See omnystudio.com/listener for privacy information.
In recognition of Endometrial Cancer Awareness Month, this episode features Jennifer Graham, a three-time cancer patient and patient advocate with the Marathon of Hope Cancer Centres Network (MOHCCN). Jennifer shares her experiences navigating breast, endometrial, and ovarian cancer, reflecting on the emotional realities of diagnosis, treatment, survivorship, and living with uncertainty. Together, we discuss the importance of support systems, how cancer shaped her perspective on life and advocacy, and the role of patient voices in improving cancer research and care. Through her story, Jennifer offers an honest and hopeful conversation about resilience, community, and moving forward through even the most difficult moments.For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca Where to learn more about us: Twitter – @GCI_Cluster Instagram – @gynecancerinitiative Facebook – facebook.com/gynecancerinitiativeTikTok – @gci_gosh
Menopause is not just “hot flashes”—it is a systemic hormonal shift that affects almost every organ system. For the emergency clinician, recognizing the symptoms of perimenopause and menopause is crucial for expanding the differential diagnosis once life-threatening conditions are ruled out. Dr. Pam Dyne joins us for a crash course on evaluating menopausal and perimenopausal patients in the ED. The “Why”: Why Menopause Matters in the ED The Mimic: Menopausal symptoms can mimic emergencies, including cardiac events, neurologic issues, and acute musculoskeletal injuries. The “Nothing Bad” Trap: After a negative workup (e.g., for chest pain or abdominal pain), telling a patient “everything is normal” often leaves them without answers. Identifying menopause as a potential etiology provides patient-centered closure and a path to treatment. Empowerment: Many medical providers are insufficiently trained when it come to menopause – ED clinicians can help patients advocate for themselves. Physiology Refresher: When the Ovaries Retire The Signal: Prior to menopause, the brain sends FSH/LH to the ovaries, and the ovaries answer with estrogen. The Shift: In menopause, the ovaries “retire.” The brain keeps shouting (higher FSH levels), but the ovaries don't respond. Perimenopause: Hormones fluctuate wildly, cycles become irregular, and symptoms are often at their peak due to inconsistency. Hormone Therapy (MHT): Debunking the Myths A major barrier to treatment is the “mass hysteria” caused by the 2002 Women's Health Initiative (WHI) study. The Correction: Modern re-analysis shows that for healthy females under 60 and within 10 years of menopause, hormone therapy is extremely safe. (There are some exceptions, including females at high risk for certain cancers) The Benefits: It has been shown to reduce all-cause mortality by 30% and has many potential health benefits, including lower the risk of Alzheimer’s, Parkinson’s, and osteoporotic fractures. The Difficult Pelvic Exam: ED “Hacks” Examining older female patients can be challenging for myriad reasons, including physical limitations and lack of proper ED pelvic exam gurneys. The Upside-Down Speculum: If you can’t use stirrups, keep the patient flat on the bed. Turn the speculum upside down (handle facing up) so it doesn’t hit the gurney. Tip: Push down on the handle; don’t pull up like a laryngoscope. Lateral Decubitus: Perform the exam with the patient on their side (top leg held up) if they cannot flex their hips. Comfort: Use liberal lubrication and consider topical lidocaine gel. The “Hidden” Problem: Always check for old/forgotten pessaries or fecal impaction in cases of pelvic pain or recurrent UTIs. Clinical Pearls: Specific Presentations 1. Post-Menopausal Bleeding Rule: Cancer until proven otherwise. Workup: Speculum exam (confirm source) + Ultrasound (measure endometrial thickness) + Endometrial biopsy (usually outpatient). 2. Genitourinary Syndrome of Menopause (GSM) Symptoms: Vaginal dryness, thinning tissue, pH changes, and recurrent UTIs (≥3 culture-proven UTIs in 12 months or ≥2 in 6 months). ED Treatment: ED docs can and should prescribe vaginal estrogen cream. It is not absorbed systemically and is highly effective at preventing future UTIs. 3. Pelvic Organ Prolapse Types: Cystocele (bladder), Rectocele (rectum), or Uterine prolapse. Exam Tip: Symptoms are often gravity-dependent. If you don’t see the bulge while the patient is supine, ask them to bear down. 4. Musculoskeletal (MSK) Syndrome of Menopause Presentation: atraumatic joint pain, tendinopathies. Cause: Estrogen receptors are located throughout the MSK system; loss of estrogen leads to inflammation and ligamentous changes. Key Takeaways for the ED Clinician Keep menopause on your differential: Don't dismiss vague aches, mood changes, or urinary issues in women aged 45–60 as “just stress.” Look at the Problem: If a patient has pelvic pain or bleeding, do the exam. You might find a simple fix, like a forgotten pessary or local atrophy. Connect to Care: If you suspect menopause is the culprit, point them toward menopause.org to find a certified practitioner. Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guest: Dr. Pamela Dyne, Professor of Clinical Emergency Medicine and Chief Physician Wellness Officer at Olive View UCLA Medical Center Resources: North Americal Menopause Society (NAMS) – Menopause.org UTIs and Estrogen: the Overlooked Link, By Ashley Winter, MD; Rachel Rubin, MD; and Howie Mell, MD, MPH. ACEP Now, February 16, 2022 American College of Obstetricians and Gynecologists (ACOG): Menopause *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
Endometrial cancer accounts for 95% of uterine cancers, which are the fourth most common cancer in women in the US. Author Karen McLean, MD, PhD, of Roswell Park Comprehensive Cancer Center joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about diagnosis and treatment of endometrial cancer. Related Content: Endometrial Cancer
In this radiology lecture, we review the ultrasound appearance of endometrial polyps! Key teaching points include: Endometrial polyps are benign The post Ultrasound of Endometrial Polyps appeared first on Radquarters.
Drs. Dizon and Campos discuss how new antibody drug conjugates like trastuzumab deruxtecan are transforming treatment options for HER2+ gynecological cancers, showing promising results even in patients with low HER2 expression. They shared impressive clinical trial successes while emphasizing the importance of ongoing research into treatment sequencing and patient safety.
Drs. Campos and Dizon explore how groundbreaking research is redefining HER2-targeted therapies in gynecological cancers, moving beyond the old one-size-fits-all approach. They spotlight the promise and ongoing challenges of customizing treatment using new biomarkers and clinical trial data.
0.5 CPD hoursTo find out more about the MIMS Learning Live Digital event mentioned at the start of this podcast, follow this link.In this episode of the Clinical Update podcast, MIMS Learning editor Pat Anderson and deputy editor Rhiannon Ashman discuss timely diagnosis of abnormal uterine bleeding, how to assess patients and management options.They draw on the expertise of MIMS Learning's professional clinical writers and speakers, to bring you key learning points around GP assessment of abnormal uterine bleeding including heavy menstrual periods, risk factors for endometrial hyperplasia and guidance on assessing and managing unscheduled bleeding on HRT.You can access the website version of this podcast, along with a list of key learning points, on MIMS Learning - and make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.Educational objectivesAfter listening to this podcast, healthcare professionals should be better able to: Recall the prevalence of abnormal uterine bleeding and why diagnosis of its cause may be delayedTake a structured history and ask about key aspects of bleedingDeploy the PALM-COEIN classification system to recall the causes of AUBList endometrial risk factors and know when to refer to cancer pathwaysUnderstand key messages from guidance on unscheduled bleeding on HRTBe alert to red flag symptoms that suggest a serious underlying causeMIMS Learning resourcesAbnormal uterine bleedingAbnormal bleeding: tips on diagnosisRecognition and referral of endometrial cancerHeavy menstrual bleeding: red flag symptomsHealth inequalities in women: menopause, pelvic floor disorders and endometriosisMIMS Learning blog Hosted on Acast. See acast.com/privacy for more information.
This is a free preview of a paid episode. To hear more, visit smokeempodcast.substack.comEmily Zanotti is a writer, a Catholic, a political operative, a mother of three, and a professional chicken tender, which is a thing. Nancy and Sarah know her from Twitter, where she is a great follow, but they're taking this relationship to the next level. Podcast guest! The three talk about the mental health benefits of putting hands in the dirt, how Emily came to define herself as conservative (and what happened when the conservative movement shifted from her), all those female troubles women rarely talk about, and the booming fertility-industrial complex.Also discussed:* Chickens and gunshots* “My goal is to not be a hypocrite”* The intellectual side of Catholicism* The beauty of having bees come to die in your garden* “2016 broke a lot of people.”* The Greeks identified endometriosis, but Western medicine didn't come up with a treatment until… last year?* Infertility as a Catholic …* The mirage of egg freezing* Storage fees for zygotes* Endometrial tissue in women's … brains??* Clocking your kids' personalities while they're in utero* Is misogyny what drives laws that allow women to die on the floor of ERs from ectopic pregnancies, or nah?Plus, Japanese New Wave vinyl! Werewolf romance fiction! Forty years and we still haven't gotten over David Bowie's pants in Labyrinth! And much more.Start the year right. Become a paid subscriber.
A viral video claims your OB/GYN can “scoop out” your period every month, and the internet ran with it. In this episode, Dr. Stephanie Hack, MD, MPH breaks down what people are actually talking about when they confuse endometrial biopsy, D&C, and endometrial ablation. She'll unpack what these procedures really do, who they're for, and why mixing them up can be misleading or even dangerous. If you want clear, evidence-based answers instead of internet myths, this one's for you.
CME credits: 1.00 Valid until: 16-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-multidisciplinary-approaches-in-the-guideline-driven-management-of-cervical-and-endometrial-cancers/37236/ This activity focuses on optimizing multidisciplinary strategies in the guideline-driven management of cervical and endometrial cancers. Dr. Brian Slomovitz presents recent and emerging clinical data for immunotherapy-based treatment strategies, explores the role of screening and biomarkers, and emphasizes interprofessional collaboration across oncology specialties. Case-based learning contextualizes key concepts and highlights guideline-concordant care for patients with cervical and endometrial cancers.=
I'm so excited to share this special episode of "FertiliTEA with Dr. D," where I had the honor of joining my dear friend and colleague, Dr. D, to talk all things fertility. As the Egg Whisperer, I'm passionate about helping people on their journey to parenthood, and it was a joy to connect with Dr. D: someone who shares my dedication and obsession for supporting patients through every step of their fertility journey. Together, we dove into the science, the stories, and the hope that drives us both in this field. In this episode, we cover: Why "perfect" embryos don't always lead to pregnancy, and what factors might be at play The latest thinking on supplements for egg and sperm quality, including CoQ10, NAD, and rapamycin How genetics, epigenetics, and the uterine environment impact implantation and pregnancy The importance of personalized fertility care, including testing for endometriosis, endometritis, and the uterine microbiome The role of weight, nutrition, and GLP-1 medications in fertility and pregnancy outcomes Advances in sperm DNA fragmentation testing and embryo selection The emotional, spiritual, and practical realities of fertility treatment, including the option of gestational carriers Resources: American Society of Reproductive Medicine (ASRM): https://www.asrm.org/ Information on supplements discussed: CoQ10, NAD+, Rapamycin Pre-implantation genetic testing (PGT-A): https://www.asrm.org/topics/topics-index/preimplantation-genetic-testing/ Endometrial receptivity and microbiome testing: ERA Test, EMMA/ALICE Test If you have questions or want to learn more, don't hesitate to reach out. Thank you for listening, and thank you to Dr. D for having me on the show! Would you like to learn more about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, December 15th, 2025 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom. Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.
Send us a textWelcome to the November Q&A! Today, we start with a topic that always stirs strong feelings—birth partners. From the gestures that truly helped to the ones that fell short, we chat about your experiences of your partner's support, presence, connection or not.Next, we respond to an emotional call for help from a sleep-deprived and emotionally exhausted mother whose husband threatens to call the cops on her for how she handled an overwhelming moment with her toddler. Today's episode includes a special guest appearance from Nancy Wainer, world-renowned midwife and the woman who coined the term VBAC. Nancy answers a listener's question about an anterior placenta in a planned VBAC and explains what her decades of experience tell us about how placentas behave in utero. We also discuss endometrial polyps and whether a biopsy could affect future fertility, how to handle conversations about home birth within a hospital work environment, and how to choose a midwife when you have numerous options and like them all. In Quickies, we cover making baby-wearing more comfortable, the myth that labor “starts” at one centimeter, chiropractic versus pelvic floor PT in pregnancy, relieving newborn gas, timing big changes during teething, postpartum nutrition, and even whether to skip airport scanners while pregnant. We end with each of us pondering which baby names we'd choose today and our favorite ways to spend a slow morning at home.VBAC: How to Plan for Success#257 | Labor & Delivery Nurses' Roundtable: How Their Hands are Tied to Doctors' Orders#273 | Special Q&A Featuring Nancy Wainer on VBAC and More********** Needed
Guest: Tanya Davis, Director, Butterfly Rising Adrienne Moore, Director ENCANA cancer action network for African American women Endometrial cancer takes the lives of over 13,000 women annually with an estimated 66,200 new cases being diagnosed each year in the U.S. Akin to uterine, endometrial affects the lining of the uterus. Incidents of this form of cancer has been increasing among Hispanic/Latino and African American women.
If menopause is caused by low estrogen, wouldn't taking more estrogen address menopause symptoms? There's more to it. Uncover the truth and learn how to address your menopause signs and symptoms naturally and effectively!Menopause is said to be caused by low estrogen, but taking estrogen comes with side effects! Estrogen hormone therapy side effects include:•Breast cancer•Endometrial cancer•Clots•Increased risk of stroke•Gallstones•Fluid retention•Increased triglycerides•Increased risk for cardiovascular problems Not only does hormone therapy cause dangerous side effects, but menopausal women are also put on medications to treat the following menopause symptoms:•Hot flashes •Weight gain/visceral fat •Mood swings•Joint pain•Low libido•Bone loss•Muscle loss •High blood pressure If menopause is caused by low estrogen, wouldn't taking more estrogen address menopause symptoms? There's more to it. Uncover the truth and learn how to address your menopause signs and symptoms naturally and effectively!Watch these videos on Healthy Keto®, intermittent fasting, and reversing insulin resistance to support your health during menopause:▶️ https://youtu.be/vMZfyEy_jpI▶️ https://youtu.be/cUXSPIi5mE0 More about testosterone pellets: https://www.myhormonetherapy.com/ 0:00 Menopause myths debunked0:35 HRT menopause side effects 1:05 Menopause symptoms 1:40 Menopause facts7:15 Estrogen and menopause 14:04 Addressing menopause symptoms naturally19:03 Testosterone hormone therapy for menopause Menopause is said to be caused by low estrogen, but taking estrogen comes with side effects! Estrogen hormone therapy side effects include:•Breast cancer•Endometrial cancer•Clots•Increased risk of stroke•Gallstones•Fluid retention•Increased triglycerides•Increased risk for cardiovascular problems Not only does hormone therapy cause dangerous side effects, but menopausal women are also put on medications to treat the following menopause symptoms:•Hot flashes •Weight gain/visceral fat •Mood swings•Joint pain•Low libido•Bone loss•Muscle loss •High blood pressure These medications also come with dangerous side effects!During menopause, estrogen drops significantly, and women stop releasing eggs. This occurs around age 52 for most women. This affects the hypothalamus, which controls the body's thermostat, body weight, appetite, and energy levels. Other hormones, such as progesterone and testosterone, also decrease. Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.
Blind biopsies leave questions unanswered. In this episode of BackTable OBGYN, host Dr. Mark Hoffman welcomes back Dr. Linda Bradley, an expert in obstetrics, gynecology, and hysteroscopy from the Cleveland Clinic, to discuss the benefits and advancements of direct visualized endometrial sampling over traditional blind biopsy techniques. ---This podcast is supported by:Medtronichttps://www.medtronic.com/en-us/healthcare-professionals/specialties/gynecology/product-portfolio.html---SYNPOSISDr. Bradley emphasizes the importance of hysteroscopy for accurate diagnosis and treatment of various gynecological issues, including abnormal uterine bleeding. They explore the limitations of blind biopsies and the advantages of hysteroscopy in detecting focal lesions, avoiding unnecessary hysterectomies, and ensuring patient safety. The discussion also touches on the economic and procedural challenges in adopting hysteroscopy more widely in clinical practice.---TIMESTAMPS00:00 - Introduction 03:30 - The Evolution of Hysteroscopy at Cleveland Clinic04:49 - Challenges and Innovations in Hysteroscopy06:30 - Clinical Insights: Direct Visualized Endometrial Sampling12:03 - Case Studies and Practical Applications15:46 - The Importance of Visual Examination in Gynecology20:03 - Advocating for Hysteroscopy in Medical Practice31:07 - Patient History and Trauma Considerations31:34 - Cancer Detection and Missed Diagnoses32:14 - Challenges with Unscheduled Bleeding32:56 - Case Study: Blood Transfusions and Hysterectomy33:38 - Importance of Hysteroscopy34:43 - Hysteroscopy Techniques and Best Practices37:41 - Ultrasound and SIS (Saline Infusion Sonohysterography) for Imaging38:45 - Post-Operative Care and Follow-Up47:41 - Environmental and Economic Considerations in Healthcare52:51 - Final Thoughts and Patient Advocacy
In this episode, I'll show you how your gut microbiome, vaginal microbiome, and endometrial microbiome all work together to influence your ability to conceive naturally or succeed with IVF. We'll take the latest peer-reviewed research and break it down into clear, actionable steps you can begin today.Hi, I'm Dr. Aumatma—a licensed Naturopathic Doctor for over 15 years, with board certification in Naturopathic Endocrinology. I'm the creator of The Restorative Fertility Method and host of the Egg Meets Sperm Podcast, which ranks in the top 5% globally.I've had the honor of becoming a 2-time best-selling author with my books Fertility Secrets and (in)Fertility: Struggles, Secrets, & Successes. Over the years, I've been recognized with awards such as Best Naturopathic Medicine Doctor (2015, 2020), Top Women in Medicine Doctor (2020, 2021), and was inducted into the Berkeley Hall of Fame in 2022.I've shared my expertise on over 100 podcasts, speaking on fertility, pregnancy, and postpartum, and have been featured as a holistic fertility expert on ABC, FOX, CBS, KTLA, MindBodyGreen, and The Bump.Through the years, I've trained hundreds of practitioners globally in holistic fertility care, and many of them have gone on to become certified in my Fertile Foundations™ system. I also founded Madre Fertility, where we offer a free Smart Fertility Analysis to help people uncover their fertility blocks and map out a personalized path to conception.In addition to my clinical work, I serve as a Medical Advisor for Mira Fertility, Element, and Feminade—three incredible innovators in fertility and women's health.Here's what you'll learn:⏱ Timestamps / Key Topics0:00 Intro – Why your microbiome matters for fertility2:10 What is the microbiome & why does it impact conception5:00 The estrobolome: How gut bacteria recycle estrogen & influence PMS, bleeding, and ovulation8:15 Gut microbiome, inflammation, PCOS, and ovulation quality12:30 Vaginal microbiome: Why lactobacillus crispatus dominance improves conception and IVF success18:00 Endometrial microbiota: How balance supports implantation23:00 Gut-vaginal-uterine connections and hormone signaling28:00 Practical stepwise plan – gut & vaginal screening, pH testing, and when to consider microbiome testing34:00 Nutrition for the microbiome: fiber, polyphenols, omega-3s, protein41:00 Lifestyle essentials: sleep, circadian rhythm, resistance training, stress reduction48:00 Targeted therapies: probiotics, prebiotics, and clinical considerations55:00 Recap – Fertility is an ecosystem
Guest: Ann Klopp, M.D., Ph.D. Endometrial cancer treatment is continuing to evolve, with surgery guiding initial decisions and new evidence showing that adding immunotherapy significantly improves outcomes in advanced disease. But key questions remain around tailoring regimens to individual patients. Dr. Ann Klopp highlights the latest advances and challenges in management, particularly in patients with pelvic recurrences. Dr. Klopp is a Professor of Radiation Oncology, the Director of Brachytherapy, and the leader of the gynecologic section at the University of Texas MD Anderson Cancer Center in Houston.
Fertility Docs Uncensored is back with a deep dive into the endometrium—your uterine lining and a key player in fertility. Hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center, this episode answers listener questions and unpacks everything you need to know about this important tissue. The docs start with uterine artery embolization and how it can impact future pregnancies—touching on risks like decreased blood flow to the baby, stillbirth, and placenta increta. They also explore different endometrial biopsies (Receptiva, ALICE, EMMA, and ERA) and how they help evaluate the lining. Endometritis and polyps are also on the table: what they mean, how often they appear, and why treatment is often recommended. The docs start with uterine artery embolization and how it can impact future pregnancies—touching on risks like decreased blood flow to the baby, stillbirth, and placenta increta. They also explore different endometrial biopsies (Receptiva, ALICE, EMMA, and ERA) and how they help evaluate the lining. Endometritis and polyps are also on the table: what they mean, how often they appear, and why treatment is often recommended. You'll also hear about stimulation options using estrogen patches or FSH, the use of modified natural cycles, and the role of hormones like prolactin and thyroid in cycle length. Even weight changes can alter hormones and ovulation. Finally, the docs explain endometrial thickness and the relationship to frozen embryo transfer (FET) success rates. Tune in for this essential guide to all things endometrium! This podcast was sponsored by Shady Grove Fertility.
In this episode, OncLive On Air® partnered with Two Onc Docs, Tawagi and Armstrong reviewed key principles in the diagnosis and management of uterine and endometrial cancers, incorporating updates in surgical approaches, adjuvant therapy selection, molecular testing, and the management of rare uterine sarcomas. The discussion outlined the epidemiology, risk factors, clinical presentation, diagnostic evaluation, staging, histologic classification, and treatment algorithms relevant to board preparation and clinical practice.
We are updating another important GYN ONC topic: endometrial (uterine) cancer. We will go over all the important details on the risk factors, presentation, diagnosis, staging & treatment options. We will also cover rare uterine malignancies at the end of the episode.
Recent evidence challenges the practice of prescribing oral antibiotics after Cesarean delivery in obese patients, finding no significant reduction in infection rates compared to standard preoperative antibiotics alone. Howard and Antonia analyze studies showing why this once-promising intervention may not be necessary.• ACOG updates delayed cord clamping guidance to minimum 60 seconds for preterm infants• Baby born at 21 weeks and zero days celebrates first birthday, highlighting advances in neonatal care• Systematic reviews show no difference between chlorhexidine and iodine for vaginal prep before hysterectomy• Conservative management of placenta accreta spectrum disorders shows improved outcomes over immediate cesarean hysterectomy• Labor arrest Cesareans have highest blood loss among non-accreta cesarean indications• New HPV testing terminology recommends "HPV detected" rather than "positive" to avoid relationship misunderstandings• USPSTF preeclampsia prevention guidelines classify 89% of pregnant women as aspirin candidates despite limited evidence• Endometrial sampling best practices include stepwise approach starting with ultrasound before considering hysteroscopyIn two weeks, Jacqueline Vidosch returns to discuss her son Noah who has trisomy 18, following a feature in the New York Times.00:00:00 Episode Introduction00:06:43 Post-Cesarean Antibiotics: Evidence Review00:17:11 Delayed Cord Clamping Updates00:22:13 Extreme Preterm Survival Case00:26:40 Vaginal Prep and Placenta Accreta Management00:30:11 Cesarean Blood Loss by Indication00:34:21 HPV Testing Language Changes00:37:45 Aspirin for Preeclampsia Prevention00:51:33 Endometrial Sampling QuestionFollow us on Instagram @thinkingaboutobgyn.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gynecologic Cancers | Faculty Presentation 2: Endometrial Cancer and Cervical Cancer — Susana Banerjee, MBBS, MA, PhD CME information and select publications
The Cancer Pod: A Resource for Cancer Patients, Survivors, Caregivers & Everyone In Between.
Tell us your thoughts on this episode!Dr. Natalie Godbee, gynecologic oncologist at City of Hope in Atlanta, Georgia, talks with Dr. Leah Sherman in a wide-ranging interview on gynecologic cancers. The conversation covers the pros and cons of the HPV vaccine, the symptoms and risk factors for ovarian, endometrial, and cervical cancers, and the benefits of integrative medicine in cancer care. Listeners will gain valuable information on early detection, treatment options, and preventive measures for these complex cancers.Dr. Godbee's bio and links to her social mediaHuman Papillomavirus (HPV) review by the National Cancer InstituteConcerns about the safety of the HPV vaccineDoes the HPV vaccine increase promiscuity in teenagers?Dramatic reductions in pre-cancer of the cervixSupport the showOur website: https://www.thecancerpod.com Become a member of The Cancer Pod Community! Gain access to live events, exclusive content, and so much more. Join us today and be part of the journey!Email us: thecancerpod@gmail.com Follow @TheCancerPod on: Instagram Bluesky Facebook LinkedIn YouTube THANK YOU for listening!
Howard and Antonia explore the evidence behind pit breaks in labor, cannabis use in pregnancy, and IUD options for hormone replacement therapy.• Pit breaks in labor lack substantial evidence of benefit when used in active labor• Current research suggests stopping oxytocin during active labor may slightly increase cesarean rates rather than decrease them• Long pit breaks (up to 8 hours) in latent labor may be beneficial by allowing rest and promoting patience• Recent systematic review shows prenatal cannabis use increases risk of low birth weight by 75%, preterm birth by 50%, and perinatal mortality by 29%• Cannabis use during pregnancy (7.2% of pregnant women) now exceeds tobacco use• Retrospective studies on doula care show association with better outcomes, but can't establish causation due to inherent differences in patients who seek doulas• 52mg levonorgestrel IUDs (Mirena/Liletta) are suitable for endometrial protection during HRT, but evidence only supports use up to 5 years• Most systematic reviews combine heterogeneous studies and shouldn't be considered level 1 evidenceWe'd love to hear your questions! Send them to us through our Instagram or website thinkingaboutobgyn.com.00:04:52 Pit Breaks in Labor00:15:32 Examining Evidence on Oxytocin Discontinuation00:26:08 Prenatal Cannabis Use and Adverse Outcomes00:36:07 Doula Care Study Analysis00:57:22 Levonorgestrel IUD Use in HRTFollow us on Instagram @thinkingaboutobgyn.
In this conversation, Dr. Shawn Tassone discusses the complexities of postmenopausal bleeding, emphasizing the importance of understanding hormone health and the potential implications of bleeding in postmenopausal women. He outlines the diagnostic procedures, including ultrasounds and endometrial biopsies, and explains the significance of various results. Dr. Tassone also addresses the management of endometrial polyps and fibroids, the common occurrence of spotting during hormone replacement therapy, and encourages women to seek medical advice when experiencing unusual symptoms. The conversation aims to educate and empower women regarding their hormonal health and the importance of early detection of potential issues. Episode Highlights: Postmenopausal bleeding should always be investigated. Ultrasounds are crucial for assessing endometrial thickness. Endometrial biopsies can be life-saving tests. Spotting can be common when starting hormone therapy. Polyps are usually benign but can cause bleeding. Understanding hormone levels is key to managing symptoms. Cancers develop over time, not suddenly. Women should not fear hormone replacement therapy. Early detection of uterine cancer is possible and important. Consulting with a physician is essential for any unusual symptoms. Episode Resources: Dr. Shawn Tassone's Practice | https://www.drshawntassone.com Dr. Shawn Tassone's Book | The Hormone Balance Bible Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormone Archetype Quiz Thank you to our sponsor, Endurance Products Company! After over 25 years of practicing medicine, I'll be the first to tell you that not all supplements are created equal. But when I discovered Dihydroberberine SR, by Endurance Products Company, I was genuinely impressed. It's highly bioavailable and outperforms standard berberine at significantly lower doses. You can explore their offerings at endur.com. Not only is the science solid, but I love that Endurance Products Company is a family-run American company that has cared about doing things right since 1978. I've started recommending Dihydroberberine to my patients who struggle with blood sugar management, and the results speak for themselves. So much so, that I personally take this supplement for helping to support healthy blood sugar levels, heart health, and tap into how my body uses fats for energy As a special offer for my audience, Endurance Products Company is providing a 10% discount on your order! Simply use the code DRT10 at checkout when you visit endur.com. Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.
Endometrial ablation has become a cornerstone procedure in the treatment of abnormal uterine bleeding, but is it the right solution for every patient that meets the indication? In this episode of the BackTable OBGYN Podcast, Dr. Ted Anderson from Vanderbilt University joins host Dr. Mark Hoffman to discuss the evolution of endometrial ablation and its contemporary utilization, including patient selection, technical considerations, and alternative treatments for abnormal uterine bleeding. --- SYNPOSIS Dr. Anderson begins by detailing the history of abnormal uterine bleeding alongside the evolution of the endometrial ablation techniques that have been used to treat it. Shifting focus to current day practice, he then shares his approach to endometrial ablation, covering patient selection and the technical aspects of his approach. Throughout the conversation, Dr. Anderson emphasizes the importance of how we define success in endometrial ablation, explaining that eumenorrhea (normal bleeding that no longer interferes with life events) is the goal, as opposed to the more traditional view that amenorrhea is the target outcome. The episode closes with a discussion on the role of alternative treatments, such as the Mirena IUD and hysterectomy for abnormal uterine bleeding. --- TIMESTAMPS 00:00 - Introduction 09:29 - History of Abnormal Uterine Bleeding and Endometrial Ablation 23:31 - Evolution of Endometrial Ablation Devices/Techniques 31:11 - Selecting the Right Patient for Ablation Success 34:38 - Post-Tubal Sterilization Ablation Syndrome 38:27 - The Role of IUDs in Managing AUB 44:07 - Reevaluating Endometrial Ablation Success Metrics 49:55 - Innovative Ablation Techniques: Cryoablation and Steam 51:48 - Adenomyosis and Fertility-Sparing Treatments 57:28 - Final Thoughts
Welcome back to today's Friday Review where I'll be breaking down the best of the week! I'll be sharing specifics on these topics: Weekly Podcast Recap Coros Pace 3 vs. Apple Watch (product review) Dostarlimab and Endometrial & Colorectal Cancer (research) For all the details tune in to today's Cabral Concept 3290 – Enjoy the show and let me know what you thought! - - - For Everything Mentioned In Today's Show: StephenCabral.com/3290 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!
Dr. Martin answers questions sent in by our listeners. Some of today's topics include: Pneumobilia Bile salts Macular degeneration Cortisol & hot flashes Licorice root tea on Reset Urine albumin Peripheral neuropathy Numbness in left arm & leg Endometrial ablation
Vincent travels to the Karolinska Institute in Stockholm to meet up with Niklas Björkström and Joakim Dillner to review their research on the endometrial immune system, and the plan to eliminate cervical cancer in Sweden. Host: Vincent Racaniello Guests: Niklas Björkström and Joakim Dillner Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server Endometrial immune system variation (Sci Immunol) Immune defense in the womb (News from Karolinska) HPV vaccination and screening for elimination (Nat Comm) Cervical cancer elimination strategies (Int J Cancer) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.
Today on The Egg Whisperer Show podcast, I'm honored to be sharing a conversation all about endometrial analysis. Originally hosted by Tiffany Stankewicz and Nasser Al Asmar of Igenomix / Vitrolife Group, this interview included Dr. Allison Rodgers and Dr. Aimee We did a deep dive on how endometrial analysis works, and the tools that are available for fertility patients to get a better understanding of what may be happening with their endometrial lining. We also talk about how endometrial receptivity testing can lead to better outcomes for patients. The truth is that up to 30% of women have pathogenic bacteria in their endometrial lining that can negatively affect an embryo's ability to implant, and the good news is that there are simple antibiotics that can improve the lining. Dr. Rodgers and I have both had a lot of experience using the tools that Igenomix has created to test the endometrium, and we have both found that they can improve a patient's chance for a successful pregnancy. They call the trio of tests “Endometrio” and it includes EMMA, ALICE, and ERA. These three tests do the following: ERA (Endometrial Receptivity Analysis) - The ERA test evaluates the stage of an endometrium to determine if a receptive or non-receptive genetic profile is present at the time of biopsy. EMMA (Endometrial Microbiome Metagenomic Analysis) - A screening test to evaluate the endometrium at the microbiological level. ALICE (Analysis of Infectious Chronic Endometritis) - ALICE detects the bacteria causing chronic endometritis to improve your patient's reproductive prognosis. Tune in to learn more about endometrial analysis and how these tests, and the science behind them, can give fertility patients more insights about their endometrium, implantation, and chances for pregnancy. Thank you for hosting, Tiffany and Nasser, and thank you for the great discussion, Allison! You can tune in to all of the discussions hosted by Igenomix at ASRM on YouTube. You can find Igenomix here. Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, November 21, 2024 at 4pm PST, where Dr. Aimee will explain Egg Freezing and there will be time to ask her your questions live on Zoom. Watch videos of Dr. Aimee answer Ask the Egg Whisperer Questions on YouTube. Sign up for The Egg Whisperer newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.
In today's episode, we discuss the use of hormone replacement therapy (HRT) and local oestrogen in all types of gynaecological cancer patients. Many women after ovarian, womb, cervical, vulval or vaginal cancers feel that they are left out of the conversation and research as so much emphasis is on the breast cancer community. So, here we are with a laser focus on menopause after gynae cancers and we hope this episode is helpful. We are joined by Mr. Vikram Talaulikar, an associate specialist at the reproductive medicine unit in University College London Hospitals NHS Foundation Trust and hon. associate professor at University College London. He explains that menopause after gynaecological cancer treatment is more challenging because it occurs suddenly and the symptoms are often more severe and persistent. We discuss the data and safety for the use of HRT and local oestrogen for:1) Ovarian cancer2) Endometrial cancer3) Cervical cancer4) Vaginal + Vulval cancerEpisode Highlights:00:00 Intro.13:05 HRT now considered for more cancer patients.14:04 HRT generally safe for most ovarian tumours.19:58 Prefer HRT after 12-24 months post-treatment.22:09 Cervical cancer: treatment options hinge on type.30:24 Post-surgery, vaginal oestrogen often necessary; discussions important.33:32 Research non-hormonal treatments before using vaginal oestrogen.38:39 Ideally see a menopause specialist early after cancer diagnosis.42:34 Sarcomas contraindicate hormone use.44:50 Holistic menopause care includes non-hormonal and local treatments.49:18 Discuss options with GP, oncologist, or nurse specialist.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub A big thanks to our trusted sponsor, The Better Menopause. I'm excited to share their amazing product, The Better Gut with you. Most women don't realize that gut health and menopause symptoms are intrinsically linked—keeping your gut happy is the foundation for overall health, through all stages of life. The Better Gut is a daily capsule packed with a unique, science-backed probiotic blend designed to survive stomach acid, reach your gut alive and help improve symptoms such as bloating, hot flushes and anxiety. Go check them out - The Better Gut is a big help for many https://thebettermenopause.com/products/better-gut?selling_plan=690396627248
In this episode, we hear the remarkable story of Wenora Johnson, a three-time cancer survivor who faced the challenges of job loss, single motherhood, and pursuing an education, all while navigating her diagnoses. Wenora shares her experiences with warmth, humor, and wisdom, offering valuable insights for anyone facing adversity. We delve into the cultural taboos surrounding cancer in her community, the critical role genetics played in her health journey, and why involving loved ones in our health decisions is so essential. Wenora's story goes beyond survival; it's about how she turned her experience into a passion for patient advocacy, making a lasting impact in the cancer community. Key Highlights: 1. Given the significant role genetics play as a risk factor for cancer, it is important to keep your family and loved ones informed. 2. Give yourself grace; you don't have to become a patient advocate fighting for systemic change. It's perfectly okay if your focus is simply on getting through today. 3. Having a supportive healthcare team that genuinely wants to see you succeed is crucial—not only for the effort they'll put forth but also for inspiring you to stay healthy and proactive in your treatment. Feeling lost in your cancer experience? We've created interactive, disease-specific maps to help you see all the paths you might face. Launching this Fall! Sign up for access here. About our guest: Wenora Johnson is a three-time cancer survivor (Colorectal, Endometrial and Basel Cell Carcinoma), Volunteer Research/Patient Advocate and Navy Veteran. As a volunteer with various organizations, she shares her understanding of policy; research; genetic testing; hereditary cancer; patient engagement and clinical trials with patients and the healthcare community. Being a Lynch Syndrome patient, Wenora advocates for genetic testing and awareness. She serves on various panels and review boards to provide extensive feedback on her role as a patient and research advocate with organizations such as CAP (College of American Pathologist); Clinical Trials Curator for Fight CRC; FORCE (Facing Our Risk of Cancer Empowered) Research Advocate, Peer Navigator and Board Member; a Consumer Reviewer for the DoD Peer Reviewed Cancer Research Program; a PCORI Ambassador and Clinical Trials Panel Member; IRB for local community hospital; NRG Oncology Patient Advocate Committee Member and the AACR Scientist~Survivor Program - presenting a poster on financial toxicities and disparities among minority patients; Center for Genomic Interpretation (CGI) Acceptable Thresholds Committee Board Chair and an External Advisory Board Member for WCG Clinical Services. She has written various patient advocate blogs and participated as a guest speaker/panelist and serves as the Community Patient Advocate for the University of Chicago Comprehensive Cancer Center and the University of Chicago Cancer Center. Wenora works in administration in the greater Chicagoland area and enjoys reading and traveling with her family. Visit the Manta Cares website Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
In this episode, we review the high-yield topic of Endometrial Polyp from the Reproductive section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Andrea Rosati. Mr. Rosati is a consultant at the Department of Gynecologic Oncology at Fondazione Policlinico Universitario Agostino Gemelli in Rome (Italy). He is currently attending a second level master "Gynecologic Oncology International Master" at the Catholic University of the Sacred Heart (Rome, Italy) accredited as a Subspecialty Fellowship by the European Society of Gynaecological Oncology. His main interest areas are gynecological cancer, surgical anatomy, and gynecologic oncology surgery. Highlights: This study evaluated the prevalence of concurrent endometrial cancer in patients with pre-operative diagnoses of atypical endometrial hyperplasia undergoing hysterectomy. Among 460 patients, 47.2% were found to have concurrent endometrial cancer. Sentinel lymph node biopsy provided prognostic and therapeutic information in 60.8% of cases. It also allowed for the adjustment of adjuvant therapy in 12.3% of high to intermediate-risk patients without increasing operative time or complication rates. The study suggests sentinel lymph node biopsy can provide valuable prognostic and therapeutic insights in managing atypical endometrial hyperplasia.
To have your question featured in a future video, please email: questions@drmdc.health
Answering your latest hormone and PCOS related questions: Relief against hirsutism Anti-androgenic therapies Endometrial hyperplasia with PCOS Moon cycling and cycle syncing your food Got a question you want me to answer next? Email me at info@laurence-annez.com LINKS MENTIONED: My 1:1 Hormone Program Fem Harmony https://laurence-annez.my.canva.site/ MASTERCLASS Mind Body alignment for the Feminine https://unique-builder-662.ck.page/603d5fcb50 Cycle Synced PCOS Recipe Bundle https://laurence-s-school-8369.thinkific.com/courses/cycle-synced-pcos-friendly-recipes PCOS Breakthrough Course https://laurence-s-school-8369.thinkific.com/courses/pcos-breakthrough PCOS holistic support group https://www.facebook.com/groups/183220068951436/ Tinkle Razors https://tinkleyourface.com/ BLOG: What to do about androgens if you have PCOS https://www.laurence-annez.com/health-wellness/androgens?rq=androgens CONNECT WITH LAURENCE: Follow me at @laurence.annez on Instagram for more updates and inspiring content. . SUPPORT THE SHOW: Help me reach more people by subscribing, rating, and reviewing on Apple Podcasts. I hope you loved this episode! If you did, take a screenshot, share to your IG stories and tag me @laurence.annez so I can share you!
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ana Luzarraga to discuss molecular profiles as predictors of endometrial recurrence. Dr. Luzarraga is a Gynecologic Oncologist currently working in the Vall d'Hebron University Hospital in Barcelona, Spain. She has completed her two years ESGO fellowship in 2023 and is currently finishing her PhD programme about molecular profile in endometrial cancer. Highlights: Molecular subgroups of endometrial cancer present distinctive recurrence patterns: p53-abn tumors relapse mostly with peritoneal and distant disease and NSMP tumors at distance. Molecular profile is a stronger independent predictor for vaginal, peritoneal, and distant recurrence than classic histologic factors. P53-abn is the sole independent predictor of peritoneal relapse. P53-abn and NSMP are independent predictors of distant recurrence.
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Andrea Rosati. Mr. Rosati is a consultant at the Department of Gynecologic Oncology at Fondazione Policlinico Universitario Agostino Gemelli in Rome (Italy). He is currently attending a second level master "Gynecologic Oncology International Master" at the Catholic University of the Sacred Heart (Rome, Italy) accredited as a Subspecialty Fellowship by the European Society of Gynaecological Oncology. His main interest areas are gynecological cancer, surgical anatomy, and gynecologic oncology surgery. Highlights: This study evaluated the prevalence of concurrent endometrial cancer in patients with pre-operative diagnoses of atypical endometrial hyperplasia undergoing hysterectomy. Among 460 patients, 47.2% were found to have concurrent endometrial cancer. According to ESGO-ESTRO-ESP classification, 71.4%, were low-risk, 9.7% intermediate, 11.1% high to intermediate and 7.8% high-risk tumors. Positive Lymph node were found in 12 patients, accounting for the 7.6% of concurrent endometrial cancers who underwent SLN biopsy. SLN biopsy allowed for the adjustment of adjuvant therapy in 12.3% of high to intermediate-risk patients without increasing operative time or complication rates.
Dr. Harvey Kliman discovered and created the Endometrial Function Test. He is Director of the Reproductive and Placental Research Unit at Yale and focuses his research on infertility and pregnancy complications. In addition to his research and teaching activities at Yale, he also consults with Physicians to evaluate complicated cases related to pregnancy loss, and poor pregnancy outcomes. I'm honored to have him join me on The Egg Whisperer Show podcast to talk about the EFT, the endometrium, and everything you need to know about implantation. Read the article on Dr. Aimee's Website. Find Dr. Kliman online, here. Do you have questions about IVF? Join Dr. Aimee for The IVF Class at The Egg Whisperer School. The next live class call is on Monday, February 12, 2024 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom. Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Checkout the podcast Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.
Dr. Natalie Crawford discusses the fertility treatment add on called the ERA test or Endometrial Receptivity Analysis test. This test is used to look at the gene profile of the endometrium to see if it fits their definition of "perfect" implantation window timing. In this episode, Dr. Crawford reviews different studies of the ERA test and whether or not this test improves treatment outcomes. Natalie answers your fertility questions in FFS-For Fertility's Sake I had to stop my stimulation on day number 7 because of hyper stimulation. What should I do? I have my retrieval coming up and previously had two failed transfers. What are your suggestions to prepare for the cycle? Can having a D&C impact your chances of getting pregnant after? I'm not getting pregnant quickly like I did before. How often should we get our fertility testing done? Should we get yearly AMH and semen analysis done? We have moved Fertility In The News to the weekly newsletter in order to keep the podcast more evergreen. If you want to sign up go to nataliecrawfordmd.com/newsletter to sign up! Don't forget to ask your questions on Instagram for next week's For Fertility's Sake segment when you see the question box on Natalie's page @nataliecrawfordmd. You can also ask a question by calling in and leaving a voicemail. Call 657–229–3672 and ask your fertility question today! Thanks to our amazing sponsors! Check out these deals just for you: Factor- Head to factormeals.com/aaw50 and use code aaw50 to get 50% off. Apostrophe- Get your first visit for only five dollars at Apostrophe.com/AAW or use the code AAW at checkout. HoneyLove- Get 20% OFF by going to honeylove.com/aaw Beam-Go to youcanbeam.com and use code “AAW” for 10% off site wide If you haven't already, please rate, review, and follow the podcast to be notified of new episodes every Sunday. Plus, be sure to follow along on Instagram @nataliecrawfordmd, check out Natalie's YouTube channel Natalie Crawford MD, and if you're interested in becoming a patient, check out Fora Fertility. Learn more about your ad choices. Visit megaphone.fm/adchoices
We have decided to move Fertility In The News to the weekly newsletter in order to keep the podcast more evergreen. If you want to sign up go to nataliecrawfordmd.com/newsletter to sign up! Natalie answers your social media questions during her segment FFS—For Fertility's Sake. Can you get pregnant with one Fallopian tube? Is an ERA worth it? Can hypothyroidism impact my ability to have a baby? My luteal phase is 10 days but my progesterone levels are normal. Is this okay? Don't forget to ask your questions on Instagram for next week's For Fertility's Sake segment when you see the question box on Natalie's page @nataliecrawfordmd. You can also ask a question by calling in and leaving a voicemail. Call 657–229–3672 and ask your fertility question today! Thanks to our amazing sponsors! Check out these deals just for you: Apostrophe- Get your first visit for only five dollars at Apostrophe.com/AAW or use the code AAW at checkout. Cozy Earth - Up to 35% off site wide when you use the code AAW on cozyearth.com Before- 20% discount on their first order with code AsAWoman at checkout on BeforeCompany.com Liquid IV- Go to liquidiv.com and use code AAW at checkout for 20% off BetterHelp - Go to BetterHelp.com/AAW today to get 10% off your first month. Athena Club-Go to athenaclub.com and use code AAW for 25% off your first order. If you haven't already, please rate, review, and follow the podcast to be notified of new episodes every Sunday. Plus, be sure to follow along on Instagram @nataliecrawfordmd, check out Natalie's YouTube channel Natalie Crawford MD, and if you're interested in becoming a patient, check out Fora Fertility. Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2026 Ivy Podcast Discovery LLC
